JQ1 is a c-Myc inhibitor, and Jones et al. found that JQ1 combined with Atorvastatin had a synergistic inhibitory effect on c-Myc and a synergistic anti-ovarian cancer effect (Jones et al., 2017). Here, MYC is linked to ovarian carcinoma.